Check out Dr. Marcus Conant speaking with host Karen Jagoda on the Empowered Patient about his journey to finding a potential functional cure for #HIV: brnw.ch/21wHtTL

Our team is attending the 31st Conference on Retroviruses and Opportunistic Infections presented by IAS–USA! We are eager to engage with our peers in the HIV research community & share the progress we're making towards finding a functional cure for HIV. brnw.ch/21wHww4

Today is National Women and Girls HIV/AIDS Awareness Day. The National HIV/AIDS Strategy provides a national strategy to accelerate efforts to end the #HIV epidemic by 2030. Click here to read a summary: brnw.ch/21wHK5a #NWGHAAD

Public biotechs have raked in $10 billion this year, and the XBI is up over 50%! Gene therapy leaders are driving the momentum. loom.ly/tbdKi2Q #FOMO #biotech #investing Are you seeing this trend too? Let us know with a 👍

On this National Native HIV and AIDS Awareness Day (#NNHAAD), we're rallying behind a national movement to empower Native communities across the US and its territories to learn about the disease, get tested, join prevention efforts, and seek care for #HIV.

#ICYMI, our Chief Science Officer, Jeff Boyle, PhD, was featured in the 2024 March issue of PharmTech Group providing commentary and insight on the development of Gamma-Delta T-cell therapies – and how we are leveraging #GeneTherapy. Read more: brnw.ch/21wI3Oy

🚨 TONIGHT! - Mar 27th, 4PM EST🚨 Catch AGT's CEO, Jeff Galvin, on DC News Now's "Moco Minute." He'll discuss HIV research from AGT and its HIV division, Addimmune, the future of the biotech industry and pushing innovation. loom.ly/23ITaZc #AGT #Addimmune #MocoMinute

More signs of continued momentum in the biotech industry! Green shoots in IPO land with @boundlessbio following last month's Kyverna Therapeutics & @altoneuro's debut on the exchanges. ecDNA oncology company will launch $100 million IPO. loom.ly/BmtSpUM $BOLD $KYTX $ANRO

We are grateful to have Dr. Marcus Conant represent our mission to find a functional cure for #HIV, especially at #CROI2024. Learn about his journey in PharmaVoice: pharmavoice.com/news/hiv-aids-…

Recent article highlights 6 recent cell & gene therapies & looks ahead to 17 more mentioned by the Alliance for Regenerative Medicine. Many have been able to leverage abbreviated pathways. loom.ly/AcVpJh4

Listen in with Dr. Marcus Conant as he discusses #genetherapy for HIV suppression with CGTLive here loom.ly/zllWHkQ

This #NYHAAD, we support Nat’l Youth HIV & AIDS Awareness Day (NYHAAD) and their mission to create meaningful and intentional spaces for young people to ask questions, learn, and talk about the impacts of HIV and their community. #StopHIVTogether #EndHIVStigma

This #NYHAAD, we support Nat’l Youth HIV & AIDS Awareness Day (NYHAAD) and their mission to create meaningful and intentional spaces for young people to ask questions, learn, and talk about the impacts of HIV and their community. #StopHIVTogether #EndHIVStigma

The future of medicine! The strategic market insight company Nova 1 values the cell & gene therapy market @ $18 billion in 2023 growing at a CAGR of 18% over the next decade. They see a near $100 billion market size by 2033. loom.ly/kpuPhu4 #genetherapy #futureofmedicine

Dr. Marcus Conant will be participating in a roundtable on cell and #GeneTherapy alongside Andrew Dietz, MD, of @ShapeTX at this year’s CMO Summit 360 on April 18 at 12:50 PM ET. Learn more: brnw.ch/21wIUh4 #CMO360

Dr. Marcus Conant will be participating in a roundtable on cell and #GeneTherapy alongside Andrew Dietz, MD, of @ShapeTX at this year’s CMO Summit 360 on April 18 at 12:50 PM ET. Learn more: loom.ly/EjJavXE #CMO360

Can genetic evidence make drugs more effective? A new study in Nature suggests YES. Drug mechanisms with genetic support have a 2.6x higher chance of success. loom.ly/NxSxjXk #genetics #science #healthcare

AGT CEO, Jeff Galvin, had a chat with HIV advocate, Raif Derrazi, to discuss the latest updates on our AGT103-T clinical trials. Discover what lies ahead in our mission to find a cure for HIV! loom.ly/jAThqIU #HIVResearch #ClinicalTrials

Tune in to Cell & Gene: The Podcast and hear Addimmune's Dr. Marcus Conant, a pioneer in HIV research, discuss our innovative cell therapy for HIV. He shares his vision for empowering patients and transforming HIV treatment. loom.ly/96TZ0jU #HIV #celltherapy #biotech

AGT has completed two clinical trials for our HIV CURE PROJECT with promising data. Now we need your help to try to take it to the finish line. Please consider donating today or sharing with someone who could. loom.ly/BioFNRo #HIVCure #HIV #Donate